Beginning Cash: The amount of cash reported by the company on its previous statement.
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Beginning Cash of $3.62M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.35M |
|
-- |
|
-- |
|
$4.52M |
|
$-4.52M |
|
$0.17M |
|
$-4.35M |
|
$-4.35M |
|
$-4.35M |
|
$-4.35M |
|
$-4.35M |
|
$-4.35M |
|
$-4.52M |
|
$-4.50M |
|
1.07M |
|
1.07M |
|
$4.69 |
|
$4.69 |
|
| Balance Sheet Financials | |
$20.01M |
|
-- |
|
$0.38M |
|
$20.39M |
|
$5.55M |
|
-- |
|
$1.72M |
|
$7.27M |
|
$13.12M |
|
$12.74M |
|
$13.12M |
|
0.26M |
|
| Cash Flow Statement Financials | |
$-13.54M |
|
$-4.28M |
|
$18.01M |
|
|
Beginning Cash |
$3.62M |
$3.82M |
|
$0.19M |
|
$1.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.14% |
|
-34.14% |
|
-21.33% |
|
-33.14% |
|
$51.32 |
|
$-12.68 |
|
$-12.68 |
|